Lifeward director granted 7,657 RSUs in equity award

Kidron Miriam reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kidron Miriam reported acquisition or exercise transactions in this Form 4 filing.

Lifeward Ltd. director Miriam Kidron received a grant of 7,657 ordinary shares through restricted stock units under the company’s 2025 Incentive Compensation Plan. These RSUs vest in four equal quarterly installments beginning three months after the March 25, 2026 grant date, aligning compensation with ongoing service.

Insider Trade Summary

Grant/Award: 7,657 shares

Grant/Award 1 txn

Insider Kidron Miriam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares, no par value per share	7,657	$0.00	$0.00

Holdings After Transaction: Ordinary Shares, no par value per share — 7,657 shares (Direct)

Footnotes (1)

1. F1. Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Lifeward Ltd. (LFWD) report for Miriam Kidron?

Lifeward Ltd. reported that director Miriam Kidron acquired 7,657 ordinary shares via a restricted stock unit grant. The award was made under the company’s 2025 Incentive Compensation Plan as equity-based compensation, rather than an open-market share purchase.

How many Lifeward (LFWD) shares were granted to Miriam Kidron and at what price?

Miriam Kidron was granted 7,657 ordinary shares through restricted stock units at a reported price of $0.00 per share. This reflects a compensatory equity award, not a cash purchase, and increases her directly held stake to 7,657 shares after the grant.

How do Miriam Kidron’s Lifeward (LFWD) RSUs vest over time?

Kidron’s 7,657 restricted stock units vest in four equal quarterly installments, starting three months after the March 25, 2026 grant date. This schedule ties receipt of shares to continued service over one year, distributing ownership gradually rather than all at once.

What plan governs Miriam Kidron’s equity award at Lifeward (LFWD)?

The award was granted under Lifeward’s 2025 Incentive Compensation Plan. This plan authorizes equity-based compensation such as restricted stock units, allowing the company to grant share-based awards to directors and other participants as part of their overall compensation packages.

Is Miriam Kidron’s Lifeward (LFWD) transaction a market buy or a compensation grant?

The transaction is a compensation grant, not an open-market buy. Form 4 shows code “A” for a grant or award acquisition, with 7,657 RSUs issued at a price of $0.00 per share, reflecting non-cash equity compensation awarded by the company.

How many Lifeward (LFWD) shares does Miriam Kidron hold after this Form 4 transaction?

After the reported grant, Miriam Kidron holds 7,657 ordinary shares directly. These come from restricted stock units that will convert into shares as they vest in four equal quarterly tranches starting three months after the March 25, 2026 grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 04:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kidron Miriam

(Last) (First) (Middle)

C/O LIFEWARD LTD.

2 CABOT RD.

(Street)

HUDSON MASSACHUSETTS 01749

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares, no par value per share	03/25/2026		A		7,657(1)	A	$0.00	7,657	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

	/s/ Almog Adar, as Attorney-in-Fact for Miriam Kidron.	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)